Cargando…

Epstein-Barr Virus, Human Papillomavirus, and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients

It is widely accepted that the Epstein-Barr virus is etiologically associated with the development of nasopharyngeal carcinoma. The human papillomavirus is also associated with inverted papilloma. We used the polymerase chain reaction technique to detect both viruses in both types of tumors. Flow cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassim, S. K., Ibrahim, S. A., Eissa, S., Zaki, S. S. A., El-Begermy, M. A., Abdou, M. H., Hassan, M. I., Khalifa, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850611/
https://www.ncbi.nlm.nih.gov/pubmed/9868598
http://dx.doi.org/10.1155/1998/260392
_version_ 1782294127375810560
author Kassim, S. K.
Ibrahim, S. A.
Eissa, S.
Zaki, S. S. A.
El-Begermy, M. A.
Abdou, M. H.
Hassan, M. I.
Khalifa, A.
author_facet Kassim, S. K.
Ibrahim, S. A.
Eissa, S.
Zaki, S. S. A.
El-Begermy, M. A.
Abdou, M. H.
Hassan, M. I.
Khalifa, A.
author_sort Kassim, S. K.
collection PubMed
description It is widely accepted that the Epstein-Barr virus is etiologically associated with the development of nasopharyngeal carcinoma. The human papillomavirus is also associated with inverted papilloma. We used the polymerase chain reaction technique to detect both viruses in both types of tumors. Flow cytometry was also used to study the DNA pattern and proliferative behavior of the tumors in relation to the viruses. EBV was detected in 13/20 (65%) of NPC specimens, and in none of IP (n = 10) or control specimens (n = 10). This indicates the contribution of EBV as an etiologic factor in NPC. Five cases of NPC (25%) were positive for HPV 16, two of them were EBV positive. Four HPV 16 positive cases were found among cases with inverted papilloma, but none among the control cases. Flow cytometry revealed that all NPC, IP, and control samples were diploid except one aneuploid NPC sample. Proliferative capacity (PC) of primary tumors was predictive of tumor recurrence in NPC. Using 13.6% as a cut-off point for PC, we were able to discriminate between high risk and low risk groups with 100% sensitivity and 86% specificity. PC can be used as a baseline prognostic parameter in NPC, making it possible to modify courses of treatment in an attempt to inhibit tumor recurrence.
format Online
Article
Text
id pubmed-3850611
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38506112013-12-11 Epstein-Barr Virus, Human Papillomavirus, and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients Kassim, S. K. Ibrahim, S. A. Eissa, S. Zaki, S. S. A. El-Begermy, M. A. Abdou, M. H. Hassan, M. I. Khalifa, A. Dis Markers Other It is widely accepted that the Epstein-Barr virus is etiologically associated with the development of nasopharyngeal carcinoma. The human papillomavirus is also associated with inverted papilloma. We used the polymerase chain reaction technique to detect both viruses in both types of tumors. Flow cytometry was also used to study the DNA pattern and proliferative behavior of the tumors in relation to the viruses. EBV was detected in 13/20 (65%) of NPC specimens, and in none of IP (n = 10) or control specimens (n = 10). This indicates the contribution of EBV as an etiologic factor in NPC. Five cases of NPC (25%) were positive for HPV 16, two of them were EBV positive. Four HPV 16 positive cases were found among cases with inverted papilloma, but none among the control cases. Flow cytometry revealed that all NPC, IP, and control samples were diploid except one aneuploid NPC sample. Proliferative capacity (PC) of primary tumors was predictive of tumor recurrence in NPC. Using 13.6% as a cut-off point for PC, we were able to discriminate between high risk and low risk groups with 100% sensitivity and 86% specificity. PC can be used as a baseline prognostic parameter in NPC, making it possible to modify courses of treatment in an attempt to inhibit tumor recurrence. IOS Press 1998 2002-06-07 /pmc/articles/PMC3850611/ /pubmed/9868598 http://dx.doi.org/10.1155/1998/260392 Text en Copyright © 1998 Hindawi Publishing Corporation.
spellingShingle Other
Kassim, S. K.
Ibrahim, S. A.
Eissa, S.
Zaki, S. S. A.
El-Begermy, M. A.
Abdou, M. H.
Hassan, M. I.
Khalifa, A.
Epstein-Barr Virus, Human Papillomavirus, and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients
title Epstein-Barr Virus, Human Papillomavirus, and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients
title_full Epstein-Barr Virus, Human Papillomavirus, and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients
title_fullStr Epstein-Barr Virus, Human Papillomavirus, and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients
title_full_unstemmed Epstein-Barr Virus, Human Papillomavirus, and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients
title_short Epstein-Barr Virus, Human Papillomavirus, and Flow Cytometric Cell Cycle Kinetics in Nasopharyngeal Carcinoma and Inverted Papilloma among Egyptian Patients
title_sort epstein-barr virus, human papillomavirus, and flow cytometric cell cycle kinetics in nasopharyngeal carcinoma and inverted papilloma among egyptian patients
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850611/
https://www.ncbi.nlm.nih.gov/pubmed/9868598
http://dx.doi.org/10.1155/1998/260392
work_keys_str_mv AT kassimsk epsteinbarrvirushumanpapillomavirusandflowcytometriccellcyclekineticsinnasopharyngealcarcinomaandinvertedpapillomaamongegyptianpatients
AT ibrahimsa epsteinbarrvirushumanpapillomavirusandflowcytometriccellcyclekineticsinnasopharyngealcarcinomaandinvertedpapillomaamongegyptianpatients
AT eissas epsteinbarrvirushumanpapillomavirusandflowcytometriccellcyclekineticsinnasopharyngealcarcinomaandinvertedpapillomaamongegyptianpatients
AT zakissa epsteinbarrvirushumanpapillomavirusandflowcytometriccellcyclekineticsinnasopharyngealcarcinomaandinvertedpapillomaamongegyptianpatients
AT elbegermyma epsteinbarrvirushumanpapillomavirusandflowcytometriccellcyclekineticsinnasopharyngealcarcinomaandinvertedpapillomaamongegyptianpatients
AT abdoumh epsteinbarrvirushumanpapillomavirusandflowcytometriccellcyclekineticsinnasopharyngealcarcinomaandinvertedpapillomaamongegyptianpatients
AT hassanmi epsteinbarrvirushumanpapillomavirusandflowcytometriccellcyclekineticsinnasopharyngealcarcinomaandinvertedpapillomaamongegyptianpatients
AT khalifaa epsteinbarrvirushumanpapillomavirusandflowcytometriccellcyclekineticsinnasopharyngealcarcinomaandinvertedpapillomaamongegyptianpatients